Filter
898
Text search:
suspension
Featured
117
234
Language
Document type
425
168
148
64
41
26
14
9
2
1
Countries
43
39
29
26
25
18
18
17
16
16
15
13
13
13
13
13
12
12
11
11
10
10
9
9
9
9
9
9
9
8
8
8
8
8
8
6
6
6
5
5
5
5
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
402
66
54
37
23
14
9
1
Toolboxes
175
47
42
40
37
34
34
27
19
17
16
13
12
11
10
10
10
9
9
8
7
5
5
4
1
National Plague Control Guidelines
recommended
Accessed Oktober 18, 2017
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak
...
The GTFCC Laboratory Support for Public Health Surveillance document provides guidelines on using DNA-based molecular techniques for identifying and monitoring Vibrio cholerae strains in cholera outbreaks. It highlights the importance of genetic sequencing for tracking transmission, detecting new va
...
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th
...
In this edition, medicines used in ICU, haemodialysis and chemotherapy unit has also been added under NEML. The medicines under disinfectants and antiseptics, intrauterine devices and barrier methods under contraceptives has been deleted and moved to medical supplies and equipment list. A section
...
NEMLIST | Sixth Edition | February 2016
Capability and Performance
Prevention and Control of Cholera Uganda
recommended
Operational Guidelines for the national and district health workers & planners.
These new approaches include use of selective chemotherapy, Rapid Diagnostic Tests (RDTs), Zinc for treatment of cholera in children and complementary use of OCV
Accessed November, 2017
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
